Condition: Colorectal Cancer Recurrent · Sponsor: Koo Foundation Sun Yat-Sen Cancer Center
This single-center, phase II clinical trial investigates the diagnostic efficacy of Ga-68-FAPI-46 PET scans in detecting colorectal cancer (CRC) recurrence during post-treatment surveillance, particularly in patients with elevated serum carcinoembryonic antigen (CEA). The study compares the sensitivity, specificity, and accuracy of Ga-68-FAPI-46 PET with the conventional F-18-FDG PET scans, aiming to enhance recurrence detection in CRC patients who underwent curative surgery. Thirty participants will be enrolled and monitored through imaging studies and clinical follow-up.
This description comes directly from the study's public registry record.
Yu Yi Huang, MD · +886 28970011 · yuyi@kfsyscc.org
Cheng Ling Yang, B.Rad. · +886 28970011 · androgyny@kfsyscc.org
Always discuss trial participation with your own doctor first.
| Koo Foundation Sun Yat-Sen Cancer Center | Taipei, Beitou, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06769828